These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19263604)

  • 1. New strategies to prevent cardiovascular risk in chronic kidney disease. Proceedings of the Sixth International Conference on Hypertension and the Kidney. February 2008. Madrid, Spain.
    Kidney Int Suppl; 2008 Dec; (111):S1-99. PubMed ID: 19263604
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension and cardiovascular risk in chronic kidney disease patients.
    Luño J; Rodriguez-Iturbe B; Ayus JC
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S157-8. PubMed ID: 17130254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings of the Third International Conference on Hypertension and the Kidney, February 2002, Madrid, Spain.
    Kidney Int Suppl; 2002 Dec; (82):S1-87. PubMed ID: 18637211
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the 5th International Conference on Hypertension and the Kidney, February 2006, Madrid, Spain.
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S157-303. PubMed ID: 18064742
    [No Abstract]   [Full Text] [Related]  

  • 5. Abstracts of the 3rd International Conference on Kidney and Hypertension. Madrid, Spain, 7-9 February 2002.
    Nefrologia; 2002; 22 Suppl 2():1-83. PubMed ID: 11894825
    [No Abstract]   [Full Text] [Related]  

  • 6. The CARI guidelines. Cardiovascular risk factors. Lipid-lowering therapy in patients with chronic kidney disease.
    Walker R;
    Nephrology (Carlton); 2005 Dec; 10 Suppl 5():S231-4. PubMed ID: 16371108
    [No Abstract]   [Full Text] [Related]  

  • 7. New strategies to prevent cardiovascular risk in chronic kidney disease.
    Luño J; Remuzzi G; Rodriguez-Iturbe B; Ayus JC
    Kidney Int Suppl; 2008 Dec; (111):S1. PubMed ID: 19034317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular, renal and other chronic diseases. Early intervention is necessary in chronic kidney disease].
    Martín de Francisco AL; Aguilera L; Fuster V
    Nefrologia; 2009; 29(1):6-9. PubMed ID: 19240765
    [No Abstract]   [Full Text] [Related]  

  • 9. Nutrition interventions to address cardiovascular outcomes in chronic kidney disease.
    Beto JA; Bansal VK
    Adv Chronic Kidney Dis; 2004 Oct; 11(4):391-7. PubMed ID: 15492977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Kidney Day 2011 : protect your kidneys, save your heart.
    Couser WG; Riella MC
    J Indian Med Assoc; 2011 Feb; 109(2):89-92. PubMed ID: 21888170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic renal disease and cardiovascular complications: inevitable or preventable? Now is the time for some intervention studies.
    Irish AB; Simons LA
    Aust N Z J Med; 1997 Jun; 27(3):273-4. PubMed ID: 9227809
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
    McCullough PA; Haapio M; Mankad S; Zamperetti N; Massie B; Bellomo R; Berl T; Anker SD; Anand I; Aspromonte N; Bagshaw SM; Bobek I; Cruz DN; Daliento L; Davenport A; Hillege H; House AA; Katz N; Maisel A; Mebazaa A; Palazzuoli A; Ponikowski P; Ronco F; Shaw A; Sheinfeld G; Soni S; Vescovo G; Zanco P; Ronco C; Berl T;
    Nephrol Dial Transplant; 2010 Jun; 25(6):1777-84. PubMed ID: 20375030
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiplatelet and anticoagulant therapy in chronic kidney disease].
    Cases A; Escolar G;
    Nefrologia; 2004; 24 Suppl(6):127-41, 187-235. PubMed ID: 15696903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk of cardiovascular disease associated to chronic renal disease. Prevalence and control degree of classical risk factors].
    García de Vinuesa S; Gómez-Campderá F; Goicoechea MA; Luño J
    Nefrologia; 2005; 25 Suppl 4():18-22. PubMed ID: 16392319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategic action of the Spanish Society of Nephrology confronting chronic renal disease ].
    Alcázar R; de Francisco AL
    Nefrologia; 2006; 26(1):1-4. PubMed ID: 16649419
    [No Abstract]   [Full Text] [Related]  

  • 17. Should nephrologists use beta-blockers? A perspective.
    Kalaitzidis R; Bakris G
    Nephrol Dial Transplant; 2009 Mar; 24(3):701-2. PubMed ID: 19073654
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anemia and cardiovascular risk in the chronic kidney disease population--which hemoglobin target should be reached?].
    Krzesinski JM; Dubois B
    Rev Med Liege; 2007; 62(5-6):366-70. PubMed ID: 17725208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.
    Rodriguez-Iturbe B; Correa-Rotter R
    Expert Opin Pharmacother; 2010 Nov; 11(16):2687-98. PubMed ID: 20426701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early origins of cardiovascular disease in pediatric chronic kidney disease.
    Patel HP
    Ren Fail; 2010 Jan; 32(1):1-9. PubMed ID: 20113258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.